Partnerships between pharma and diagnostic device companies are becoming increasingly important as pharma companies seek ways to differentiate their products, and precision medicine demands the need for companion diagnostics. Commercial market access, value, and regulatory needs require close coordination between pharma and diagnostic device partners. As both entities have distinct business models, investment paradigms, and tolerance for business risk, partnering and deal term negotiations can be challenging. Join us for a panel discussion about the creative solutions that can bridge these gaps and lead to win-win successful long term partnering relationships.